![](/img/cover-not-exists.png)
A randomized, controlled trial evaluating the efficacy and safety of BTH1677 in combination with bevacizumab, carboplatin, and paclitaxel in first-line treatment of advanced non-small cell lung cancer
Engel-Riedel, Walburga, Lowe, Jamie, Mattson, Paulette, Richard Trout, J., Huhn, Richard D., Gargano, Michele, Patchen, Myra L., Walsh, Richard, Trinh, My My, Dupuis, Mariève, Schneller, FolkerVolume:
6
Language:
english
Journal:
Journal for ImmunoTherapy of Cancer
DOI:
10.1186/s40425-018-0324-z
Date:
December, 2018
File:
PDF, 1.68 MB
english, 2018